Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
1.83M
-
Shares change
-
+305K
-
Total reported value, excl. options
-
$43.1M
-
Value change
-
+$7.73M
-
Put/Call ratio
-
4.14
-
Number of buys
-
25
-
Number of sells
-
-14
-
Price
-
$23.60
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q4 2017
57 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q4 2017.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.83M shares
of 69.1M outstanding shares and own 2.65% of the company stock.
Largest 10 shareholders include BlackRock Inc. (494K shares), CITADEL ADVISORS LLC (338K shares), Vanguard Group Inc (225K shares), STATE STREET CORP (138K shares), NORTHERN TRUST CORP (96.5K shares), WELLS FARGO & COMPANY/MN (63.4K shares), GEODE CAPITAL MANAGEMENT, LLC (60.6K shares), Bank of New York Mellon Corp (56.3K shares), AQR CAPITAL MANAGEMENT LLC (43.4K shares), and MORGAN STANLEY (30.4K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.